Drugs

Can you tell which of these statements is false?

A new study published in the Annals of Internal Medicine suggests that healthcare providers aren’t prescribing these new options as much as they should.

Paramedics increasing their scope and working in new patient care models means there is now a higher risk of medication errors, ISMP Canada says.

The rate of weight loss impacts all-cause mortality in OA patients.

Novo Nordisk’s weekly injection is approved for weight loss among patients diagnosed with obesity.

A U.S. and Canada study shows that ASA 300 mg daily does not improve risk of breast cancer recurrence or survival in individuals with high-risk nonmetastatic breast cancer.

It's not just physical symptoms: Remember the emotional, cognitive and relational impacts that antidepressant withdrawal can have on your patients.

Aminophylline 25 mg/mL injection will be available from Septa Pharma under Exceptional Import Approval by Health Canada to fulfill the Tier 3 shortage.